What You Should Know:
– Turquoise Health, a platform empowering healthcare transparency through data and analytics, today announced a $30M Series B investment led by Adams Street Partners, with participation from Yosemite and existing investors Andreessen Horowitz and BoxGroup.
– The new funding will enable the company to onboard new customers and expand its healthcare pricing transparency platform,
Tackling the Transparency Challenge
Healthcare pricing remains a labyrinth, often frustrating patients and hindering informed decision-making. Turquoise head-on addresses this issue with its sophisticated, multi-stakeholder platform. As Tom Bremner, Partner at Adams Street and incoming board member, states, “Turquoise makes healthcare pricing and packaging look easy. I’m thrilled to partner with them as they transform healthcare transactions.
Beyond Hospital Pricing
Building on its core expertise in hospital price transparency, mandated by federal regulations, Turquoise has expanded its platform to encompass:
- Payer and provider contract management: Streamlining agreements between healthcare entities.
- Consumer transparency compliance: Ensuring patients have access to clear cost information.
- Advanced platform-based analytics: Providing data-driven insights for informed decision-making.
This feature-rich platform will be crucial as healthcare organizations navigate the evolving landscape of price transparency regulations extending beyond hospitals in the coming years.
“As we see price transparency legislation take shape through 2027 and beyond, Turquoise accelerates support for healthcare organizations as they embed transparency and simplicity at every step in the transaction,” says Turquoise CEO, Chris Severn.
